TBL1XR1 and gastric cancer: Interestingly, in GC, colorectal cancer, and breast cancer besides ESCC, analysis of datasets from GEO showed that TBL1XR1 levels were significantly correlated with VEGF-C expression, and silencing TBL1XR1 resulted in decrease in VEGF-C expression.